BioCorRx (BICX) Cash & Equivalents Growth (5y) (2015 - 2026)
BioCorRx (BICX) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.58% |
| Dec 31, 2025 | -25.12% |
| Sep 30, 2025 | -21.02% |
| Jun 30, 2025 | -40.21% |
| Mar 31, 2025 | -58.54% |
| Dec 31, 2024 | -49.37% |
| Sep 30, 2024 | -87.98% |
| Jun 30, 2024 | -71.94% |
| Mar 31, 2024 | -16.25% |
| Dec 31, 2023 | -25.27% |
| Sep 30, 2023 | -8.61% |
| Jun 30, 2023 | -19.32% |
| Mar 31, 2023 | 157.28% |
| Dec 31, 2022 | 43.33% |
| Sep 30, 2022 | -25.86% |
| Jun 30, 2022 | -33.31% |
| Mar 31, 2022 | -33.85% |
| Dec 31, 2021 | -9.63% |
| Sep 30, 2021 | 56.02% |
| Jun 30, 2021 | -9.76% |